SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-012651
Filing Date
2022-08-08
Accepted
2022-08-08 16:36:35
Documents
18
Period of Report
2022-08-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmbr-20220804x8k.htm   iXBRL 8-K 47626
2 EX-4.1 tmbr-20220804xex4d1.htm EX-4.1 125722
3 EX-4.2 tmbr-20220804xex4d2.htm EX-4.2 134675
4 EX-99.1 tmbr-20220804xex99d1.htm EX-99.1 263569
5 EX-99.2 tmbr-20220804xex99d2.htm EX-99.2 10408
6 EX-99.3 tmbr-20220804xex99d3.htm EX-99.3 10131
  Complete submission text file 0001558370-22-012651.txt   836244

Data Files

Seq Description Document Type Size
7 EX-101.SCH tmbr-20220804.xsd EX-101.SCH 3729
8 EX-101.DEF tmbr-20220804_def.xml EX-101.DEF 2725
9 EX-101.LAB tmbr-20220804_lab.xml EX-101.LAB 17262
10 EX-101.PRE tmbr-20220804_pre.xml EX-101.PRE 10072
12 EXTRACTED XBRL INSTANCE DOCUMENT tmbr-20220804x8k_htm.xml XML 4812
Mailing Address 110 ALLEN ROAD, SUITE 401 BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD, SUITE 401 BASKING RIDGE NJ 07920 914-205-3481
Timber Pharmaceuticals, Inc. (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 221144955
SIC: 2834 Pharmaceutical Preparations